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Stimulation of B and T cells via the antigen receptor, by phorbol ester or by phorbol ester and 
ionomycin, leads to nuclear translocation of the inducible transcription factor NF-KB, comprising 
the p50 and p65 re/-related polypeptides. In this report we show that c-tel is a component of 
the antigen receptor-induced xB binding proteins in both B and T cells. Whereas NF-~cB can 
be induced by phorbol ester alone, optimal induction of c-tel requires stimulation by both phorbol 
ester and ionomycin, the dual signal that is necessary for proliferation of untransformed lympho- 
cytes. Furthermore, c-tel induction is blocked by the immunosuppressive drug FK506 that is 
known to inhibit B and T  cell activation,  c-rel-dependent  transactivation of the interleukin-2 
receptor ot chain (Ib2Rot) promoter is augmented by coexpression  of calcineurin,  suggesting 
the involvement of a calcineurin-dependent intracellular pathway.  Our results  identify c-tel as 
a target of immunosuppressive  agents and illustrate the similarity of activation pathways in both 
B and T  ceils. 
S 
tim.  ulation of B  and  T  cells via  the  antigen receptor 
triggers  a  signaling cascade that  results  in  clonal  cell 
proliferation characteristic  of the immune response. Altera- 
tion of the resting program of gene expression is brought 
about by inducible nuclear factors that transmit the signal 
generated at the plasma membrane to the cell nucleus. Sev- 
eral transcription factors have been identified that are induced 
in response to antigen receptor cross-linking, or its pharmaco- 
logic equivalent, the combined action of phorbol esters and 
calcium ionophore. We, and others, have shown that antigen- 
receptor cross-linking on both B and T cells induces the factors 
NF-KB, AP-1, and cAMP response element-binding protein 
(CREB) (1-4).  However,  these proteins can be induced by 
the action of phorbol ester alone on these cells, a signal that 
is not sufficient to induce proliferation. A notable exception 
is NF-AT, a nuclear factor present in activated T cells, whose 
induction  requires  the  dual  signal  of phorbol  ester  and 
ionomycin (5). We have recently shown that both signals are 
also required to induce an indistinguishable DNA-binding 
protein in B cells, indicating that NF-AT should be regarded 
more generally as a factor of activated  lymphoid ceils (6). 
Because it is likely that proteins that are induced in response 
to the complete proliferative  signal will play a critical role 
in normal and aberrant  immune responses, it is essential to 
identify factors that satisfy this criterion. 
The immunosuppressive drugs cyclosporin A and FKS06 
block B  and T  cell proliferation  (7-9).  The intracellular 
pathway of drug action in T  cells has been recently eluci- 
dated.  Both drugs bind to distinct cytosolic receptors and 
the drug receptor complexes inhibit the enzymatic activity 
of the calcium and cahnodulin-dependent serine/threonine 
phosphatase,  calcineurin (10-13).  NF-ATp/c, the preexisting 
cytoplasmic component of NF-AT (14-16),  has been impli- 
cated as a direct target of calcineurin (17, 18). In this model, 
calcium-dependent translocation of NF-ATp/c to the nucleus 
is  triggered by dephosphorylation of this protein by cal- 
cineurin. In contrast, the mechanism of immunosuppressive 
action in the B cell compartment is unknown. The observa- 
tion that slg, but not LPS, mediated B cell proliferation is 
blocked by these drugs (9,  19) suggests that they interfere 
with a calcium-dependent pathway, but no nuclear mediators 
of the effects of immunosuppressive  drugs in B cells have been 
identified.  We have recently demonstrated that NF-AT in- 
duction in splenic B cells is suppressed by cyclosporin A, in- 
dicating that this protein may be partly responsible  for the 
effects of these drugs in B cells (6). In this report we show 
that  the proto-oncogene c-tel  is  a  component of antigen 
receptor-induced KB-binding proteins in both B and T cells. 
Whereas NF-KB (pS0/p65 tel related heterodimer) can be in- 
duced by phorbol ester alone, optimal induction of c-tel re- 
quires stimulation by both phorbol ester and ionomycin. Fur- 
thermore, c-rel induction in both B and T  cells is blocked 
by FK506.  The effect of FK506 can be reversed by excess 
rapamycin, and c-rel-dependent  transactivation of the IL-2Rot 
promoter is augmented by coexpression of calcineurin, sug- 
gesting the involvement of a calcineurin-dependent intracel- 
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suppressive action and illustrate the fundamental similarity 
of activation pathways  in  B  and T  cells. 
Materials and Methods 
Cell Culture and Inductions.  The murine B lymphoma cell line 
Bal 17 was maintained in RPM1  1640 (GIBCO BRL, Gaithers- 
burg, MD) supplemented with 10% heat-inactivated fetal bovine 
serum, 50/zM B-mercaptoethanol, 50 U/rrd penicillin, and 50 #g/ml 
streptomycin.  CeLls were cultured  at  a  density of 5-6  x  10  s 
cells/ml during stimulation.  Bal 17 B ceils were stimulated for 1-2 h 
(37~  with 20 ng/ml PMA (Sigma Chemical Co., St. Louis, MO), 
20 ng/ml PMA, and 2/~M ionomycin (Calbiochem-Novabiochem 
Corp., La Jolla, CA) or a~nity-purified goat anti-mouse F(ab')2 
fragment, # chain specific, (anti-Ig; Jackson ImmunoResearch Labs., 
West Grove, PA) at 10-20/~g/ml. D5h3 is a hybridoma derived 
from Ar-5 cells by fusion with a Tcg- variant of BW 5147 thy- 
morea ceils. DSh3 cells were grown in DMEM medium supple- 
mented with 10% FCS, 2 mM glutamine, 10 mM Hepes, 50 U/m1 
penicillin, 50/~g/ml streptomycin, and 50 ~tM B-mercaptoethanol. 
These cells were stimulated for 4-5 h at a density of 5-6  x  10  s 
cells/rot.  Inducer  concentrations were 40  ng/ml  PMA,  2  #M 
ionomycin. D5h3 cells were also activated with cross-linked mAb 
to murine CD3e. 2Cll  (anti-CD3e) antibody was used at 1:100 
dilution, and was cross-linked by immobilized rabbit anti-hamster 
antibody (N. L. Cappel Laboratories, Cochranville, PA) as described 
previously (2). FK506, a generous gift from Dr. Stuart Schreiber, 
(Harvard University, Cambridge, MA) was used at a final concen- 
tration of 2 nM where indicated and was added 5-7 rain before 
addition of other inducing agents. 
Nuclear Extracts and Electrophoretic Mobility Shift Assays.  Prepa- 
ration of small scale nuclear extracts from untreated activated cells 
and labeling of oligonucleotide probes were done as described pre- 
viously (2). The binding site (H2K) derived from the murine H2K 
MHC class I gene promoter was isolated as an EcoRI-HindlII frag- 
ment from the plasmid subclone (20) and used as a probe. In vitro 
binding reactions were carried out at room temperature with 6-10 
/~gm of nuclear extract for 15 min. 
Antibody Shifts and Competitions.  For antibody shifts, standard 
binding reactions were carried out, followed by addition of either 
rabbit anti c-tel antiserum 1050 gift of  Dr. N. Rice (National Cancer 
Institute, Frederick, MD) (21) or normal rabbit serum (NRS) and 
overnight incubation on ice. 1-1.5 ~1 of a 1:5 dilution of these anti- 
sera were used in 20-#1 binding reactions.  For competition assays, 
where indicated, 1-2/~g of competitor peptides were included in 
the binding reaction followed by overnight incubation with anti- 
bodies as described above. Sequences of the peptides used for com- 
petitions are:  (a) c-rel: NH~-Asn-Pro-Asp-Asp-Leu-Ala-Arg-Met- 
GIu-Thr-Pro-Ser-Met-Ser-Pro-Thr-Asp-Leu-Cys; and (b) p50: NH2- 
Met-Pro-His-Gly-Tyr-Gly-Gln-Glu-Gly-Pro-Ile-Glu. 
Western Blots.  Western blot analysis was done using the enhanced 
chemiluminescence  detection system (Amersham Corp., Arlington 
Heights, IL). Nuclear extracts (10 ktgm) derived from unstimu- 
lated and differently stimulated Bal 17/D5h3 cells were separated 
by electrophoresis through 8.8% SDS--polyacrylamide gels. Proteins 
were transferred to ECL-hybond nitrocellulose membranes (Amer- 
sham). Primary anti-c-rel antibody (SC71 (X); Santa Cruz Biotech, 
Inc., Santa Cruz, CA) or anti-re/B antibody (SC 226(X); Santa 
Cruz Biotech, Inc.) was used at 1:500 dilution for 3-4 h at room 
temperature, followed by peroxidase-conjugated  anti-rabbit immu- 
noglobulin (Amersham) at 1:1,000. Chemiluminescent detection 
was carried out according to the manufacturer's specifications. 
Transfections and CAT Assays.  2  x  107 $194 plasma  (B) cells 
or Jurkat T cells were transfected with 5/xgm of the reporter plasmid 
containing a fragment of the Ib2R.c~ promoter (residues  -317 to 
- 227) cloned upstream of the c-Jos gene TATA box at  - 56 using 
the DEAE dextran procedure. The reporter plasmid was cotrans- 
fected with 5/~gm of either c-tel expression vector or the calcineurin 
expression vectors (12), or both together as indicated. In transfec- 
tions containing only one transactivator,  total DNA was made up 
to 15 ~gm using pTZ 18R as carrier DNA. Transfected cells were 
left untreated, or treated with PMA (40 ng/ml) and ionomycin 
(500 nM), 24 h after transfection. For FK506 treatment, the drug 
was added at a concentration of 10 nM immediately after the trans- 
fection procedure. Whole cell extracts made 48-60 h after trans- 
fection were analyzed for CAT enzyme activity as previously de- 
scribed (22) using 100-150/~gm of heat-treated (65~  for 7 rain) 
extract. 
Results 
Antigen Receptor Cross-linkinr  or the Dual Signal of Phorbol 
Ester and Calcium Ionophore, Is Required for Optimal c-rel Induc- 
tion  in B  and T  Cells.  We have previously shown  that  in 
splenic B cells NF-KB is constitutively expressed, but is fur- 
ther induced following cross-linking of surface immunoglob- 
ulin (anti-Ig), or after stimulation with phorbol ester alone 
(PMA) or phorbol ester and ionomycin (P+ I) (1). Because 
multiple rel family members can bind to the KB DNA probe 
(23),  in this  study we have characterized the induction  of 
the c-tel component of inducible KB binding  proteins.  Bal 
17 is a B  cell line that  has been extensively used to study 
signal transduction via surface immunoglobulin (24, 25), and 
it exhibits a pattern of NF-xB induction similar to that seen 
in  splenic B  cells.  Nuclear extracts from Bal  17 cells were 
analyzed by electrophoretic mobility shift assays (EMSA) 1 in 
the presence or absence of anti--c-rel antibodies, using a DNA 
fragment containing a NF-KB-binding site. Whereas increased 
KB binding was evident in cells treated with PMA alone, P+ I 
or anti-Ig, only nuclear extracts made from P+I-treated,  or 
anti-Ig-treated  Bal  17 cells,  revealed an additional  "super- 
shifted" nucleoprotein complex in the presence of anti-c-rel 
antibody (Fig. 1 A, lane 3, bold arrow).  Ionomycin treatment 
by itself did not induce KB binding proteins over the levels 
constitutively present in Bal 17 cells (data not shown).  We 
conclude that P+ I or anti-Ig  signals,  but not PMA alone, 
induce c-tel containing DNA-binding proteins in these cells. 
To confirm that the super-shifted complex contained c-rel de- 
terminants, competitor peptides were included during incu- 
bation of the extract and antiserum.  The c-tel peptide used 
to generate the anti-c-rel antiserum abolished the super-shift 
(Fig.  1 A, lane 4), whereas an equivalent amount of irrele- 
vant peptide had no effect (lane 5), supporting the idea that 
the super-shifted complex contains c-rel protein.  The small 
amount of the super-shifted complex probably reflects both 
1  Abbreviations used in this paper: CN,  calcineurin; CsA, cyclosporin A; 
EMSA, electrophoretic mobility shift assays; P+I,  phorbol ester and 
ionomycin. 
1092  C-reI Expression in Lymphocytes Figure  1.  c-tel  induction  in B and 
T cellg (A) Electrophoretic  mobility 
super-shift assays using the  NF- 
~cB-binding  site  from the H2K gene 
promoter and nuclear extracts de- 
rived from Bal 17 cells treated with 
PMA and ionomycin.  Anti-c-re/an- 
tiserum  or  normal  rabbit serum 
(NRS) were  incubated  as described, 
with  in  vitro  binding  reactions. 
(Bold arrow)  Position  of the anti c-rel 
specific  super-shifted  complex.  (Thin 
arrow) Points to  the  position  of 
NF-KB band. Specificity  of super- 
shifted complex  was determined  by 
incubation of competitor peptides 
with the antiserum before binding 
analysis. Lane  I, no added antibody; 
lane 2, NR.S; lane 3, anti-c-re/an- 
tiserum with no added  peptide; lane 
4, anti-c-re/antibody and 1/~g of 
c-rel peptide used to produce the 
anti-serum; lane 5,  anti-c-tel anti- 
body and 2/~g of a 12-amino acid 
peptide from the COOH terminus 
of NF-gB, pS0. (B) Western blot 
analysis of nuclear c-rel in Bal 17 
calls. Nuclear proteins from cells 
treated as indicated were separated 
by SDS-PAGE,  transferred  to nitro- 
cellulose membranes and  probed 
with anti-c-tel anti-serum. P, PMA 
alone; P+I, PMA and ionomycin; 
anti-lg, goat anti-mouse/~ F(ab')2 
fragment; 5-7 represent a different 
set of extracts than those used in 
lanes 1-4. I, ionomycin alone. (Arrow) Position of 72-kD c-tel band. (C) Electrophoretic mobility super-shifr assays using D5h3 (T) cells activated 
with PMA and ionomycin. Specificity  of super-shifted complex was judged by in vitro peptide competition assays. Lane 1, no added antibody; lane 
2, NRS; lane 3, anti-c-tel  anti-serum; lane 4, anti-c-re/plus 2 #g c-tel peptide; lane 5, anti-c-re/plus  1 #g c-rel  peptide; lane 6, anti-c-tel  plus 2/~g 
p50 peptide. Super-shifted  complex is indicated by the bold arrow, while the thin arrow points to the NF-KB  band. The band below is likely to be 
the nucleoprotein complex generated by the p50 homodimer. (D) Western blot analysis of c-tel induction in D5h3 T cells. Nuclear proteins from calls 
treated as indicated were separated by SDS-PAGE, transferred to nitrocellulose membranes, and probed with anti-c-tel  anti-serum.  -, PMA alone; 
P+I, PMA and ionomycin;  anti-CD3,  anti-CD3e monoclonal antibody, 2Cll and secondary  rabbit anti-hamster antibody; I, ionomyein alone. Lanes 
5-7 represent a different set of extracts than those used in lanes 1-4.  Arrow indicates position of the 72-kD c-tel band. 
the low abundance  of nuclear c-rel  and inefficient recogni- 
tion  of the  DNA/protein  complex by the antiserum. 
Induction of c-tel was also directly visualized by Western 
blot analysis of nuclear extracts (Fig.  1 B). Nuclear extracts 
from untreated Bal 17 cells contain detectable levels of c-tel 
(Fig. 1 B, lane 1 ), which were significantly increased by P+I 
or anti-Ig treatment  (Fig.  1 B, lanes 3  and 4).  PMA  treat- 
ment  alone induced c-tel,  albeit at much lower levels (Fig. 
1 B,  lane 2)  and  ionomycin treatment  alone had  no  effect 
(Fig. 1 B, compare lanes 5 and 7). We conclude that optimal 
induction of DNA-binding c-tel requires anti-Ig stimulation 
or  the  dual  signals  of P+I. 
To extend these results, we examined c-tel induction in T 
cells. Nuclear extracts prepared from DSh3 hybridoma T  ceils 
(26) were used in electrophoretic mobility super-shifr assays 
(Fig.  1 C).  These T  cells contain barely detectable levels of 
NF-KB in EMSA. Treatment with PMA alone for 4 h resulted 
in a modest increase of the NF-rB complex, whereas higher 
levels were seen in cells treated with P+I or anti-CD3 mono- 
clonal antibody (data not shown). Similar to the observation 
in Bal 17 cells, an additional slower mobility nucleoprotein 
complex (bold arrow) was observed in the presence of anti-c- 
tel antibody only in extracts from anti-CD3  or P+I-treated 
cells (Fig. 1 C, lane 3). Specificity of the super-shifted com- 
plex was  assessed by peptide competition assays  (Fig.  1 C, 
lanes 4-6).  Inclusion of 1 or 2/zg of peptide used to generate 
the anti-c-tel  antiserum, abolished the super-shifted complex 
(Fig.  1 C, lanes 4  and 5) whereas an irrelevant peptide had 
no effect (Fig. 1 C, lane 6). Western blot analysis of nuclear 
extracts confirmed the c-rel induction pattern seen in EMSA 
(Fig. 1 D). Untreated, or PMA-treated, DSh3 cells contained 
low levels of nuclear c-rel  (Fig.  1/9,  lanes  I  and 2),  which 
were significantly increased by P+ I or anti-CD3  treatment 
(Fig.  1 D,  lanes 3  and 4).  In addition,  treatment  of D5h3 
cells with ionomycin alone showed only a slight  induction 
of c-rel (Fig.  1 D, compare lanes 5 and 7). We conclude that 
in T  cells as well,  nuclear DNA-binding  c-rel is induced in 
response to T  cell receptor or P+ I signals. These results em- 
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signals in both B and T  lymphocytes. 
c-rel Induction  Is Suppressed by FK506.  The immunosup- 
pressive drugs cyclosporin A (CsA) and FKS06 have been 
shown to inhibit  T  cell responses (7-9).  Both drugs bind 
to distinct intracellular receptors and the drug/receptor com- 
plexes  inactivate  the  calcium  and  calmodulin-dependent 
serine/threonine phosphatase and calcineurin (10--13, 27). Sev- 
eral studies in T cells have shown that both drugs affect the 
induction of several  early activation-specific genes, including 
transcription  factors such as NF-AT, NF-KB, NF-IL2A  (5, 
28-31), that presumably mediate the secondary steps of cel- 
lular activation leading to proliferation. In these earlier studies, 
NF-KB induction was seen to be only partially inhibited by 
FKS06 and was therefore considered  to be of  little consequence 
for immunosuppression. In further exploring this effect,  Frantz 
et al. have  recently shown that calcineurin may participate in 
NF-xB (pS0/p65) induction by indirectly stimulating I-xBot 
inactivation (32). Our observation that induction of the c-rel 
component of KB binding proteins  required  a Ca  2+  signal 
in addition to a PMA signal, prompted us to explore the effects 
of immunosuppressive drugs on the induction of this pro- 
tein.  We find by Western blot analysis (Fig. 2),  as well as 
in vitro mobility super shift assays  (Fig. 3), that c-rel  induction 
is abolished by treatment of Bal 17 and D5h3 cells with ei- 
ther 200 nM CsA (data not shown) or 2 nM FKS06. 
In Bal 17 cells, total nuclear c-tel assayed  by Western blots 
was induced approximately twofold in cells treated with PMA 
alone, and approximately sixfold in cells treated with either 
P+I or anti-Ig (Fig. 2 A, lanes 3 and 5). The levels ofc-rel 
observed with P+ I or anti-Ig were reduced to those seen with 
PMA alone in the presence of FKS06 (Fig. 2 A, lanes 4 and 
6), and the drug had no effect on the low levels of c-tel in- 
duced by PMA alone (data not shown).  Thus, induction of 
c-rel by P+I, or anti-Ig treatment of Bal 17 cells is sensitive 
to low concentrations  of FK506, suggesting  that some of 
the observed effects of the drug on B cell proliferation may 
be due to inhibition of  c-tel function. Results from three in- 
dependent sets of nuclear extracts were quantified by den- 
sitometry and the average  induction is shown below each lane 
in Figs. 2, A  and/g 
Western blot analysis of nuclear c-tel expression in D5h3 
(T) cells also showed dramatic reduction of this protein in 
extracts prepared from cells that were stimulated with P+ I 
or anti-CD3, in the presence of FKS06 (Fig. 2 B). Further- 
more, optimal c-rel induction in primary adult thymocytes 
also required the combined action of  P+ I, and induction was 
diminished in the presence of FK506 (33). We conclude that 
in both B and T cell lines, signals transduced via the surface 
receptors are required for optimal induction of nuclear c-rel 
and that this process is markedly inhibited by CsA and FKS06. 
We further confirmed the inhibition of c-rel induction by 
FKS06 using electrophoretic mobility super-shift assays. In 
extracts from P+ I-treated Bal 17 cells, an additional  super- 
shifted nucleoprotein complex was observed in the presence 
of anti c-tel antibodies (Fig. 3 A, lane 4). Consistent  with 
the immunoblotting analysis, this  band was not observed  when 
the extracts from P+I- and FK506-treated  cells were used 
in this assay (Fig. 3 A, lane 6). P+I-treated DSh3 cell ex- 
tracts also showed a super-shifted nucleoprotein complex in- 
dicating the presence of DNA-binding c-tel protein (Fig. 3 
B, lane 4). Treatment of DSh3 cells with P+ I in the presence 
of FKS06 led to a marked reduction of the total  induced 
roB-binding nucleoprotein complex (Fig. 3 B, lanes 5 and 6), 
and loss of the anti c-tel-dependent  super-shifted complex. 
These results suggest either that a large proportion of the 
Figure  2.  c-tel induction is sup- 
pressed by  FK506  in  Bal  17  and 
DSh3 cells. (A) Western blot anal- 
ysis of Bal 17 cells stimulated as in- 
dicated in the presence of FKS06. 
P,  PMA  alone;  P+I,  PMA  and 
ionomycin;  P+I+F,  PMA  and 
ionomycin in the presence of 2 nM 
FK506; anti.lg+F, goat anti-mouse 
/z F(ab')2 fragment  in the presence 
of 2 nM FK506.10 #gm of nuclear 
proteins  were  separated  by  SDS- 
PAGE, transferred to nitrocellulose 
paper  and  probed  with  anti-c-tel 
anti-serum  (Santa  Cruz Biotech). 
Arrow  indicates  the  72-kD  c-tel 
band.  Numbers  below  the  lanes 
show  the levels of c-tel expression 
after stimulation  and FK506 treat- 
ment normalized  to untreated  Bal 
17 nuclear extracts (lane I ). These 
figures represent the average  of  3 sets 
of independently generated extracts. 
(B)  Western  blot  analysis of c-tel 
suppression by FKS06 in D5h3 cells. 
10  /xgm of extracts  derived from 
cells treated as indicated were analyzed. Arrow indicates position  of c-rel protein.  Numbers indicate the levels of c-tel induction and suppression relative 
to untreated  cells (lane 1 ),  and represent  the average of 3 sets of independently  generated  extracts. 
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tel family members was also sensitive to FK506 as observed 
in Jurkat cells  (32). 
The sensitivity of other rel family members was further 
studied by immunoblotting. In both Bal 17 and D5h3 cells, 
rel B protein was induced to similar levels by treatment with 
either PMA alone or P+ I (Fig.  4, A  and B, lanes 2 and 3 ), 
suggesting that a calcium signal was not required for its in- 
duction. Consistent with this idea, inclusion of FKS06 during 
P+I treatment did not affect rel B levels in either cell type 
(Fig.  4, A  and B, lane 4).  PMA-treated HeLa cell extracts 
were included in these experiments as a positive control (Fig. 
4, A  and B, lane 5). Analysis of p50 expression showed no 
alterations in the levels of this protein in this panel of nuclear 
extracts (data not shown). These results further indicate that 
rel proteins are differentially sensitive to the effects of FK506. 
Figure  3.  Electrophoretic  mo- 
bility super-shift analysis of  c-tel sup- 
pression by FK506  in Bal  17 and 
D5h3 cells. (A) Bal  17 cells were 
stimulated as shown above the lanes 
and nuclear extracts generated were 
used in in vitro binding assays in the 
presence of  NRS or anti-c-re/serum 
(anti-c-re/) as described in Fig. 1 A. 
P+I+F cells treated  with phorbol 
ester, ionomycin, and 2 nM FK506. 
Bold  arrow  indicates  the  c-tel- 
specific  super-shift  and  the  thin 
arrow  the  NF-rB  complex.  (B) 
Nuclear  extracts  from  differently 
stimulated D5h3 ceUs  were analyzed 
by EMSA as described above. Anti- 
c-tel specific super-shift is indicated 
by the bold arrow. 
Rapamycin Reverses FK506 Inhibition  of c-tel Induction.  Al- 
though the major cytosolic receptor for FK506  (FKBP12) 
is different from that of cyclosporin A (cyclophilin A), both 
drugs when bound to their intracellular receptors are believed 
to affect cellular activation by a common mechanism, that 
is, by inhibiting calcineurin, a Ca2+/calmodulin dependent, 
and serine/threonine phosphatase. The drug rapamycin com- 
petitively inhibits FK506 binding to FKBP12, but the resulting 
rapamycin/FKBP12 complex does not inhibit calcineurin ac- 
tivity (34, 35). Therefore, rapamycin reversal of FK506 inhi- 
bition has been considered to be an indication of the involve- 
ment of  calcineurin in the process being studied. To determine 
whether suppression of c-rel induction by FK506 occurred 
via the calcineurin pathway, we carried out rapamycin com- 
petition experiments (Fig.  5). In Bal 17 B cells, 2 nM or 0.5 
nM FK506 significantly reduced c-rel induction by P+ I (Fig. 
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Figure  4.  Western blot analysis 
of nuclear tel B in Bal 17 and D5h3 
cells. (A) 10-20  #g of nuclear ex- 
tracts from Bal 17 cells stimulated 
with various inducing agents were 
separated by SDS-PAGE,  transferred 
to  nitrocellulose  membrane  and 
probed  with  anti-tel  B  antibody 
as described  in  the  Materials  and 
Methods section. HeLa P is nuclear 
extract from phorbol ester induced 
HeLa cells. Arrow indicates the po- 
sition of  tel B protein. (B) 10-20/~g 
of nuclear  extracts  derived  from 
D5h3 cells treated as indicated were 
analyzed by immunoblotting. Arrow 
indicates the position of tel B protein. Figure  5.  FK506  inhibition  of 
c-rel induction is reversed by rapa- 
mycin. (A) Western blot analysis of 
Bal 17 nuclear extracts.  10/zgm of 
nuclear protein from cells treated as 
indicated above each lane were sepa- 
rated by SDS-PAGE, transferred to 
nitrocellulose and probed with anti- 
c-tel anti-serum  (Santa Cruz Bio- 
tech); lane 3, FK506 2 nM; lane 4, 
FKS06 0.5 riM; lane 5, P+I+2 nM 
FKS06  +  500 nM rapamycin; lane 
6,  P+I+500  nM rapamycin,  c-tel 
band  is  indicated  by  the  arrow. 
Rapamycin  was added first to the 
cell  cultures,  followed  by  FK506 
10 min hter and then inducers were 
added after a further 5 min. (B).  Western blot analysis of D5h3 nuclear extracts derived from cells treated as indicated,  c-tel band  is indicated by the 
arrow.  Drugs were added at the same concentrations  as described above. 
5 A, lanes 3 and 4). A 250-fold molar excess of rapamycin 
did not affect c-tel induction by P+I (Fig. 5 A, lane 6) but 
completely reversed FK506-dependent inhibition of c-tel in- 
duction (Fig. 5 A, lane 5).  The same pattern was true in 
D5h3 cells. FKS06-mediated  inhibition of  c-tel  induction (Fig. 
5 B, lane 4) was significantly diminished in the presence of 
excess rapamycin (Fig. 5 B, lane 5). As expected, rapamycin 
had no effect on the induction of c-tel by P+I (Fig. 5 B, lane 
6).  These results strongly suggest a role for calcineurin in 
c-rel  induction in B and T  lymphocytes, and identify c-tel 
as a nuclear target  in the calcineurin pathway. 
IL  2Rol Gene Induction  Is Enhanced by Cakineurin Expression. 
c-tel has been implicated in the activation of  the Ib2R.c~ gene, 
which is induced in response to mitogenic stimulation of  both 
B and T  lymphocytes.  Tan et al.  (36) showed  that  over- 
expression of c-rel in the Jurkat subline J.LEI transactivated 
a reporter plasmid containing the 5' regulatory region of the 
IL-2Rcr gene. We have shown that this IL-2Rc~ sequence is 
optimally activated in non-lymphoid cells by a combination 
of  p50, c-tel and serum response factor (J. Pierce et al., manu- 
script submitted for publication).  To assess whether calci- 
neurin-dependent  pathways participate in the generation of 
transcriptionally  active c-tel protein, we assayed the effects 
of  calcineurin expression on the transactivation of an IIr 
promoter containing reporter plasmid by c-tel. In $194 (plasma) 
cells, c-tel expression directed by the cytomegalovirus pro- 
moter and enhancer was insufficient to activate the reporter 
plasmid, in the presence or absence of PMA and ionomycin 
(Fig.  6 A). Lack of induction by cotransfected c-tel in the 
presence of PMA and ionomycin may be due to low c-tel ex- 
pression  or inefficient activation  of intra-cellular  calcium- 
dependent pathways in these terminally differentiated plasma 
cells. Coexpression of a calcineurin deletion mutant lacking 
the auto-inhibitory domain (ACaM-AI) resulted in threefold 
activation of transcription  which was further increased by 
PMA and ionomycin treatment (Fig. 6 A). Consistent with 
the proposed role of the auto-inhibitory domain, a cotrans- 
fected calcineurin (CN) gene transactivated reporter plasmid 
expression only in the presence of PMA and ionomycin (Fig. 
6 A). CN-mediated activation of the Ib2Rc~ promoter was 
diminished by treatment of the transfected cells with FK506 
(Fig. 6 A). These results are consistent with a role for CN 
in generating transcriptionally  active c-tel. 
To extend the functional analysis, we examined the effect 
of  CN expression  on a cotransfected  IL-2Rc~  promoter plasmid 
in Jurkat T cells. Expression of ACaM-AI alone, transacti- 
rated the IL-2Roe promoter 4.5-fold (Fig. 6 B) in these cells. 
We interpret this to indicate that the presence of the deregu- 
lated phosphatase  in these cells activated endogenous  KB- 
binding proteins that transactivate  the Ib2Rot promoter. Coex- 
pression of c-tel with ACaM-AI increased the expression level 
of the reporter plasmid, indicating  that CN stimulated the 
transcription  activity of transfected c-tel.  Note that in the 
conditions  of our assays, neither c-tel alone, nor CN alone, 
affected Ib2Rot expression (Fig. 6 B). Furthermore, induc- 
ible expression observed in the presence of ACaM-AI was 
suppressed by FK506. These experiments demonstrate that 
CN-dependent pathways increase the transcriptional activity 
of a cotransfected c-rel gene, as well as activate endogenous 
KB-binding proteins that are necessary  for IL-2Rot expression. 
Discussion 
We have shown that the proto-oncogene  c-rel is induced 
by PMA and ionomycin treatment orb and T lymphoid cells, 
or by stimulation of cells via the respective antigen receptors. 
The more sensitive Western blot assay revealed six- to eight- 
fold induction of nuclear c-rel in the B and T cell lines, and 
DNA-binding c-tel was only detected by antibody super-shift 
in extracts derived from optimally stimulated cells. The ap- 
parent low abundance of the super-shifted complex is likely 
to be an underestimate of the amount of DNA binding, and 
therefore presumably functional, nuclear c-rel protein.  First, 
only a fraction of the nuclear c-rel may be bound the H2K- 
xB probe being used in these assays and second, only a subset 
of the DNA-bound protein may be super-shifted by the anti- 
serum. In contrast to many other early response genes, such 
as c-j~s, c-jun, c-myc,  and egr-l, which are induced in response 
to phorbol ester alone, the dual signal requirement for c-rel 
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Figure  6.  Coexpression  of CN activates c-rel-mediated transcription  in B and T cell lines. (A) Activation of the IIr  promoter in S194 (plasma) 
cells by coexpression of c-rel and CN. S194 plasma (B) cells were transfected with a reporter plasmid containing a fragment of the IL-2Rot promoter 
(residues  -317 to  -227) cloned upstream  of the c-fis gene TATA box at  -56 and expression vectors for murine c-rel and CN as indicated above the 
bars. Transfected cells were left untreated,  treated  with PMA and ionomycin,  or with PMA, ionomycin  and FK506  as indicated below the graph. 
FK506 was used at a final concentration of I0 riM. Chloramphenicol  acetyl transferase activity was assessed in whole cell extracts 48 h after transfection 
and is indicated as the percentage of substrate chloramphenicol  converted to the acetylated form (/eft y axis). CAT enzyme activity was also normalized 
to the levels present  in the absence of cotransfected  transactivatory  plasmids  and is shown on the right y axis. The values shown  are the average of 
three sets of transfection  experiments  carried out in duplicate.  (/7) Transactivation of the IL-2Rot promoter by CN in Jurkat cells. 5/~gm of IL-2Rot 
promoter containing reporter plasmid  was transfected  into 2  ￿  107 Jurkat cells together with expression vectors containing the murine c-tel gene; 
the complete CN gene indicated  as CN or a deletion that removes the auto-inhibitory domain (indicated as ACaM-AI).  In transfections where only 
one transactivator  was used,  total DNA was made up to 15 #gm using pTZ18R.  FK506 was used at  10 nm final and added to the cells at the time 
of transfection.  All experiments  shown were performed in the absence of phorbol ester and ionomycin treatment to minimize the induction of endoge- 
nous  KB-binding proteins.  Results  shown are the average of five experiments  performed  in duplicate. 
induction implicates this proto-oncogene as a key participant 
in lymphocyte proliferation. 
Cyclosporin  A  (CsA)  and FKS06 inhibit B and T  cell 
proliferation.  The effects of these drugs are best character- 
ized in T cells where three different DNA elements have been 
shown to confer FK506 sensitive transcription activation (14, 
35-37).  However, the mechanism of drug action on the B 
cell compartment is less clear. We have recently shown that 
a factor indistinguishable  from T cell NF-AT is induced in 
splenic B cells activated via slg, and that the induction is sen- 
sitive to CsA treatment (6). In this report we show that c-rel 
induction in both B and T cells is blocked by FK506. Excess 
rapamycin competed away the FK506 effect, suggesting that 
c-rel induction requires a CN-dependent intracellular  step. 
Furthermore, neither tel B induction nor p50 expression is 
sensitive to FK506 suggesting that tel proteins are differen- 
tially regulated in lymphocytes. 
Unlike NF-AT  or octamer-associated protein-1  (OAP-1), 
NF-KB can be induced by a PMA signal alone. However, higher 
levels of NF-KB are induced by the combined action of PMA 
and ionomycin, and CsA or FK506 reduce NF-KB levels to 
that observed in the presence of PMA alone, suggesting that 
the  drugs  affect  the  Ca2+-dependent  NF-KB induction. 
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Increased NF-xB induction in the presence ofionomycin  may 
occur by translation-dependent (28) or posttranslational mech- 
anisms (32). Frantz et al. have proposed that FK506 inhibi- 
tion  of posttranslational  NF-KB induction  is  caused  by 
disruption of a CN-dependent pathway that normally syner- 
gizes with PMA to inactivate I-~Bot (32). The signaling re- 
quirements for c-rel induction that we describe mimic the 
known properties of NF-AT and OAP-1, and the requirement 
for ongoing protein synthesis suggests that c-rel may be a 
part of the translation-dependent  NF-xB induction in Jurkat 
cells (28). 
To show that c-rel suppression by FK506 affects gene ex- 
pression, we analyzed IL-2Rol gene induction by c-tel.  The 
IL-2Kc~ gene is expressed in activated B and T lymphocytes. 
The promoter region of this gene contains binding sites for 
several factors, including a KB site that is essential for the 
induction of this gene by the HTLV-1 tax gene product and 
T cell receptor signals (37-39).  We demonstrate that trans- 
activation of the IL-2Ro~ gene promoter by c-tel is augmented 
by coexpression  of active CN and suppressed  by FK506. These 
results support a role for CN in generating transcriptionally 
active c-rel and suggest that c-rel suppression by immunosup- 
pressive drugs may be the mechanism by which IL-2Rc~ in- duction is abolished by these drugs.  The characteristics  of 
c-tel induction that we have found are consistent with this 
protein being a critical,  immunosuppressive sensitive, com- 
ponent that is necessary for IL-2Rot expression. We have pre- 
viously shown that in untransformed T  cell clones,  the IL- 
2R~ gene is induced in response  to T  cell receptor cross- 
linking  and  suppressed  by  CsA  (40).  Whereas  the  NF- 
xB-binding site in the I~2Rc~ promoter (IL-2Rol-B)  was 
necessary for inducible expression of the transfected gene, NF- 
KB levels detected by EMSA were not significantly affected 
by CsA treatment of the cells. These observations suggested 
that the CsA suppressible  factor that activates  the IL-2Rot 
promoter is not the bulk KB binding activity detected by 
EMSA,  which  is  primarily p50/p65  NF-KB. The  results 
presented in this paper suggest that the relatively small propor- 
tion of DNA-binding c-rel  that is induced by TcR signals 
may regulate IL-2Rot gene transcription. Suppression of this 
factor by FK506 inhibits IL-2Ro~  expression without any ap- 
parent effect on the induced NF-KB seen in EMSA. Further- 
more, induction of II~21~ol mRNA required ongoing pro- 
tein synthesis.  This observation further supports a role for 
c-tel in activating the IL-2Rc~ promoter, as we have found 
that c-rel induction in response  to PMA and ionomycin re- 
quires protein synthesis, whereas NF-KB induction is post- 
translational. 
Sequence elements homologous to the KB element of the 
immunoglobulin x gene enhancer are present in a variety of 
viral and cellular regulatory sequences. For example,  several 
lymphokine genes,  such as IL-2, IL-3, II~4, GM-CSF, and 
TNF-~, whose induction is blocked by FKS06, contain KB- 
related sequences in their promoters (41). Although the specific 
rel-family members that activate these promoters are not yet 
known, our results suggest that c-tel may play an important 
role in the FK506-sensitive expression of these genes. We pro- 
pose that c-relis a common target ofimmunosuppressive drugs 
in B and T  lymphocytes. 
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